Recent News

521 News Items found
Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
In the Lab
In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.
New treatments developed at MSK focus on both common and rare cancers.
In the Clinic
An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.
Neurons created from embryonic stem cells
In the Lab
A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.
Pictured: Viviane Tabar
In the Lab
Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.
MSK investigators Michael Berger and David Solit.
Finding
A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.
Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.
Cancer biologist Andrea Ventura
In the Lab
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
Pictured: Pseudomonas aeruginosa
In the Lab
MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
Pictured: Kinisha Gala
Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of the curriculum.
Pictured: Ping Chi
In the Lab
Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.